{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:43:02Z","timestamp":1790718182981,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier","isbn-type":[{"value":"9780128162378","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pmbts.2018.07.009","type":"book-chapter","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:36:49Z","timestamp":1536197809000},"page":"1-22","source":"Crossref","is-referenced-by-count":109,"title":["Adult Stem Cells for Regenerative Therapy"],"prefix":"10.1016","author":[{"given":"Narasimman","family":"Gurusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrhman","family":"Alsayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeja","family":"Rajasingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Rajasingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2018.07.009_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4419-7037-4_11","article-title":"Adult stem cells and their niches","volume":"695","author":"Ferraro","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2015.09.003","article-title":"Adult mammalian neural stem cells and neurogenesis: five decades later","volume":"17","author":"Bond","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12265-016-9708-y","article-title":"Stem cell therapy for the heart: blind alley or magic bullet?","volume":"9","author":"Bruyneel","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(03)12458-0","article-title":"Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy","volume":"361","author":"Hagege","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/rme.10.65","article-title":"Skeletal myoblasts for cardiac repair","volume":"5","author":"Durrani","year":"2010","journal-title":"Regen Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0035","doi-asserted-by":"crossref","first-page":"I213","DOI":"10.1161\/hc37t1.094929","article-title":"Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2018.07.009_bb0040","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1038\/ncpcardio0416","article-title":"Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops","volume":"3","author":"Steendijk","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0045","doi-asserted-by":"crossref","first-page":"I108","DOI":"10.1161\/CIRCULATIONAHA.105.000521","article-title":"Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients","volume":"114","author":"Hagege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jmcc.2001.1507","article-title":"Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting","volume":"34","author":"Reinecke","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0055","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/01.RES.0000125294.04612.81","article-title":"Evidence for fusion between cardiac and skeletal muscle cells","volume":"94","author":"Reinecke","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1083\/jcb.200212046","article-title":"Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth","volume":"163","author":"Chazaud","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0065","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1161\/CIRCULATIONAHA.107.757617","article-title":"Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium","volume":"118","author":"Farahmand","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jtcvs.2004.11.044","article-title":"Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha","volume":"130","author":"Azarnoush","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasche","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4244\/EIJV6I7A139","article-title":"Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial","volume":"6","author":"Duckers","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0090","doi-asserted-by":"crossref","first-page":"Ii247","DOI":"10.1161\/01.CIR.100.suppl_2.II-247","article-title":"Autologous transplantation of bone marrow cells improves damaged heart function","volume":"100","author":"Tomita","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature02069","article-title":"Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes","volume":"425","author":"Alvarez-Dolado","year":"2003","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nm1040","article-title":"Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation","volume":"10","author":"Nygren","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0115","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0120","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.RES.0000264508.47717.6b","article-title":"Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry","volume":"100","author":"Assmus","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00392-013-0574-1","article-title":"Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure","volume":"102","author":"Honold","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0130","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.304353","article-title":"Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes","volume":"115","author":"Cogle","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","article-title":"Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy","volume":"115","author":"Henry","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0145","first-page":"639","article-title":"Utility of mesenchymal stromal cells for myocardial infarction. Transitioning from bench to bedside","volume":"61","author":"Psaltis","year":"2013","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0160","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.03.022","article-title":"Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial","volume":"168","author":"Perin","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0170","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1073\/pnas.0903201106","article-title":"Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity","volume":"106","author":"Quevedo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","article-title":"Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model","volume":"111","author":"Silva","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0180","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcin.2010.05.016","article-title":"Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy","volume":"3","author":"Psaltis","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0185","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcp.22081","article-title":"Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations","volume":"223","author":"Psaltis","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0190","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCRESAHA.110.222703","article-title":"Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation","volume":"107","author":"Hatzistergos","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/86498","article-title":"Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function","volume":"7","author":"Kocher","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.0000046450.89986.50","article-title":"Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia","volume":"107","author":"Kawamoto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/eurheartj\/ehu007","article-title":"Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial","volume":"35","author":"Nasseri","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0215","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","article-title":"Monitoring of bone marrow cell homing into the infarcted human myocardium","volume":"111","author":"Hofmann","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0220","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.0502678102","article-title":"Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function","volume":"102","author":"Linke","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0225","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0230","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0235","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature03215","article-title":"Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages","volume":"433","author":"Laugwitz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0240","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1073\/pnas.2132126100","article-title":"Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.stem.2011.10.002","article-title":"Adult cardiac-resident MSC-like stem cells with a proepicardial origin","volume":"9","author":"Chong","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvs427","article-title":"The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair","volume":"97","author":"Koninckx","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13287-015-0196-9","article-title":"Cardiac Bmi1(+) cells contribute to myocardial renewal in the murine adult heart","volume":"6","author":"Valiente-Alandi","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature05383","article-title":"Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization","volume":"445","author":"Smart","year":"2007","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCRESAHA.111.300010","article-title":"ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells","volume":"112","author":"Sereti","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0270","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1073\/pnas.0500169102","article-title":"Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure","volume":"102","author":"Urbanek","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.109.871905","article-title":"Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction","volume":"121","author":"Tang","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0280","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.112.001075","article-title":"Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy","volume":"128","author":"Bolli","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0285","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0290","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0295","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/CIRCULATIONAHA.109.909093","article-title":"Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts","volume":"121","author":"Zaruba","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0305","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0310","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/emmm.201303626","article-title":"Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction","volume":"6","author":"Malliaras","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0315","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/stem.1736","article-title":"Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells","volume":"32","author":"Xie","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0325","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0330","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/eurheartj\/ehu196","article-title":"Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy","volume":"36","author":"Aminzadeh","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0335","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0340","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0345","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0350","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.109.865154","article-title":"Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells","volume":"120","author":"Nelson","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0355","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/CIRCRESAHA.114.300556","article-title":"Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges","volume":"114","author":"Lalit","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/cne.901240303","article-title":"Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats","volume":"124","author":"Altman","year":"1965","journal-title":"J Comp Neurol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/scientificamerican0599-48","article-title":"New nerve cells for the adult brain","volume":"280","author":"Kempermann","year":"1999","journal-title":"Sci Am"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0370","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuron.2011.05.001","article-title":"Adult neurogenesis in the mammalian brain: significant answers and significant questions","volume":"70","author":"Ming","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0375","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cell.2011.05.024","article-title":"In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics","volume":"145","author":"Bonaguidi","year":"2011","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0380","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.stem.2008.07.004","article-title":"Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain","volume":"3","author":"Mirzadeh","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0385","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(00)80783-7","article-title":"Subventricular zone astrocytes are neural stem cells in the adult mammalian brain","volume":"97","author":"Doetsch","year":"1999","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12688\/f1000research.12684.1","article-title":"Radial glial cells in the adult dentate gyrus: what are they and where do they come from?","volume":"7","author":"Berg","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0395","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1073\/pnas.1508545112","article-title":"Tangential migration of neuronal precursors of glutamatergic neurons in the adult mammalian brain","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-neuro-071013-014134","article-title":"Functions and dysfunctions of adult hippocampal neurogenesis","volume":"37","author":"Christian","year":"2014","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0405","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature04404","article-title":"GABA regulates synaptic integration of newly generated neurons in the adult brain","volume":"439","author":"Ge","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0410","doi-asserted-by":"crossref","first-page":"630932","DOI":"10.1155\/2015\/630932","article-title":"Clinical trial of human fetal brain-derived neural stem\/progenitor cell transplantation in patients with traumatic cervical spinal cord injury","volume":"2015","author":"Shin","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","article-title":"Human neural stem cell transplantation in ALS: initial results from a phase I trial","volume":"13","author":"Mazzini","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0425","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes","volume":"74","author":"Riley","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0430","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12887-017-0859-z","article-title":"Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12967-017-1149-0","article-title":"Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy","volume":"15","author":"Liu","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0440","first-page":"37","article-title":"Administration of autologous bone marrow-derived stem cells for treatment of cerebral palsy patients: a proof of concept","volume":"11","author":"Bansal","year":"2016","journal-title":"J Stem Cells"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0445","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcyt.2014.01.008","article-title":"Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial","volume":"16","author":"Mancias-Guerra","year":"2014","journal-title":"Cytotherapy"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2018.07.009_bb0450","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.3727\/096368912X633798","article-title":"Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life","volume":"21","author":"Sharma","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12967-016-0880-2","article-title":"Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy","volume":"14","author":"Canesi","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0460","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/scd.2015.0074","article-title":"Involvement of immune responses in the efficacy of cord blood cell therapy for cerebral palsy","volume":"24","author":"Kang","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0465","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcyt.2014.09.010","article-title":"Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors","volume":"17","author":"Wang","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0470","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jcyt.2013.06.001","article-title":"Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study","volume":"15","author":"Wang","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5876-11-21","article-title":"Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy","volume":"11","author":"Chen","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0480","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/stem.1304","article-title":"Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial","volume":"31","author":"Min","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0485","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jcyt.2014.10.011","article-title":"Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety","volume":"17","author":"Zali","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0490","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0495","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0500","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0505","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0510","first-page":"151","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Suarez-Monteagudo","year":"2009","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/rme.10.97","article-title":"Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke","volume":"6","author":"Battistella","year":"2011","journal-title":"Regen Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann Neurol"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2018.07.009_bb0525","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"21","author":"Friedrich","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0530","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clineuro.2012.04.030","article-title":"Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-a prospective clinical observation","volume":"115","author":"Li","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0535","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0540","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2018.07.009_bb0545","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3727\/096368914X684961","article-title":"A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients","volume":"23","author":"Qiao","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0550","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3988\/jcn.2016.12.1.14","article-title":"Clinical trials of adult stem cell therapy in patients with ischemic stroke","volume":"12","author":"Bang","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0555","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12883-017-0955-6","article-title":"Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke","volume":"17","author":"Shichinohe","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0560","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0565","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14570","article-title":"Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0570","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ejh.12843","article-title":"Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma","volume":"98","author":"Gettys","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0575","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2014.322","article-title":"Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation","volume":"50","author":"Brioli","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0580","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2015-01-621268","article-title":"Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm","volume":"125","author":"Aoki","year":"2015","journal-title":"Blood"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0585","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","article-title":"Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"8","author":"Ye","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0590","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0595","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic mesenchymal precursor cells in type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0600","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3727\/096368913X665576","article-title":"Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study","volume":"23","author":"Bhansali","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0605","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo-controlled comparative study","volume":"26","author":"Bhansali","year":"2017","journal-title":"Stem Cells Dev"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0610","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ebiom.2015.11.003","article-title":"Modulation of autoimmune T-cell memory by stem cell educator therapy: phase 1\/2 clinical trial","volume":"2","author":"Delgado","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0615","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1741-7015-11-160","article-title":"Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial","volume":"11","author":"Zhao","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0620","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","article-title":"Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study","volume":"12","author":"Packham","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0625","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0630","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10238-013-0266-1","article-title":"Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells","volume":"15","author":"Dave","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0635","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0640","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/pedi.12072","article-title":"Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial","volume":"15","author":"Giannopoulou","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0645","first-page":"1045","article-title":"Isolation of retinal progenitor and stem cells from the porcine eye","volume":"13","author":"Gu","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0650","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2015.08.003","article-title":"Three-dimensional structure of the mammalian limbal stem cell niche","volume":"140","author":"Grieve","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0655","doi-asserted-by":"crossref","first-page":"20448","DOI":"10.1074\/jbc.M115.662940","article-title":"Transcription factor PAX6 (Paired Box 6) controls limbal stem cell lineage in development and disease","volume":"290","author":"Li","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0660","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0161-6420(95)30842-1","article-title":"Cytologic evidence of corneal diseases with limbal stem cell deficiency","volume":"102","author":"Puangsricharern","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0665","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","article-title":"Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium","volume":"349","author":"Pellegrini","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0670","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/ICO.0b013e31826215eb","article-title":"Complications of keratolimbal allograft surgery","volume":"32","author":"Baradaran-Rafii","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0675","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/ICO.0000000000001409","article-title":"Prospective clinical trial of corneal reconstruction with biomaterial-free cultured oral mucosal epithelial cell sheets","volume":"37","author":"Kim","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0680","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10561-016-9575-4","article-title":"Long-term result of autologous cultivated oral mucosal epithelial transplantation for severe ocular surface disease","volume":"17","author":"Prabhasawat","year":"2016","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0685","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/ICO.0000000000001228","article-title":"Cellular therapy with human autologous adipose-derived adult stem cells for advanced keratoconus","volume":"36","author":"Alio Del Barrio","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173575","article-title":"Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration","volume":"12","author":"Geng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0695","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","article-title":"Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study","volume":"7","author":"Oner","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0700","doi-asserted-by":"crossref","first-page":"408495","DOI":"10.1155\/2015\/408495","article-title":"Stem cell therapy for corneal epithelium regeneration following good manufacturing and clinical procedures","volume":"2015","author":"Ramirez","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0705","doi-asserted-by":"crossref","first-page":"281870","DOI":"10.1155\/2015\/281870","article-title":"Cultivated oral mucosa epithelium in ocular surface reconstruction in aniridia patients","volume":"2015","author":"Dobrowolski","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0710","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13287-015-0020-6","article-title":"Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell-clinical trial)","volume":"6","author":"Siqueira","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0715","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-015-0009-1","article-title":"Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series","volume":"6","author":"Bobba","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0720","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.14-15415","article-title":"Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings","volume":"56","author":"Park","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0725","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/CIRCULATIONAHA.106.659730","article-title":"Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling","volume":"115","author":"Zeng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0730","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00395-013-0346-0","article-title":"A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice","volume":"108","author":"Hong","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0735","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0740","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.0000055313.77510.22","article-title":"Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization","volume":"107","author":"Yamaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0745","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1073\/pnas.0604144103","article-title":"Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy","volume":"103","author":"Sasaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.009_bb0750","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCRESAHA.111.249052","article-title":"Biomaterials to enhance stem cell function in the heart","volume":"109","author":"Segers","year":"2011","journal-title":"Circ Res"}],"container-title":["Progress in Molecular Biology and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318301121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318301121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:21:41Z","timestamp":1720570901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117318301121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128162378"],"references-count":149,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2018.07.009","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}